Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Histopathology and spatial transcriptomics jointly map myofiber-specific pathological programs in mTORC1-driven myopathy
Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee
Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee
View: Text | PDF
Research Article Cell biology Muscle biology

Histopathology and spatial transcriptomics jointly map myofiber-specific pathological programs in mTORC1-driven myopathy

  • Text
  • PDF
Abstract

Skeletal muscle is composed of heterogeneous myofiber types and non-myocyte populations. Myopathies occur in many diseases, but the mechanisms driving these pathologies remain largely unknown, partly because conventional approaches cannot link histopathological features to molecular states at single-fiber resolution. To address this challenge, we brought histopathology and spatial transcriptomics together by applying high-resolution Seq-Scope technology to a mouse model of mTORC1 hyperactivation. Cross-sections from the extensor digitorum longus (EDL) and soleus (SOL), two muscles with distinct fiber-type compositions, were profiled to determine how transcriptome changes are linked to histopathological outcomes. mTORC1 hyperactivation elicited distinct, fiber type–dependent pathological programs. Type I and IIa fibers were largely resistant to mTORC1-induced pathology, exhibiting relatively limited morphological alterations. In contrast, type IIx fibers diverged into opposing fates: in SOL, they underwent abnormal enlargement associated with sustained growth signaling, cytoskeletal remodeling, and impaired proteostasis; in EDL, they developed basophilia associated with increased RNA content and lipid-, oxidative-, and nucleotide metabolism–related signatures. Within EDL, type IIb fibers displayed heterogeneity with discrete transcriptional states. Non-myocytic populations, including macrophages and fibroblasts, accumulated preferentially in SOL, forming a fibrotic microenvironment associated with inflammation, remodeling, and hypertrophy. These findings provide a link between histopathological phenotypes and molecular states at single-fiber resolution.

Authors

Jer-En Hsu, Qingyang Zhao, Weiqiu Cheng, Hyun Min Kang, Susan V. Brooks, Myungjin Kim, Jun Hee Lee

×

Figure 2

Identification of fiber type–specific responses to mTORC1 hyperactivation.

Options: View larger image (or click on image) Download as PowerPoint
Identification of fiber type–specific responses to mTORC1 hyperactivatio...
(A) Schematic of the analytical workflow for fiber type–specific differential expression (DE) analysis comparing control (homeostasis) and mutant (hyperactivation) muscle. Upregulated genes determined by Wald’s test (adjusted P value < 0.05, log2FC > 1.5). (B) Representative expression patterns of genes that are exclusively upregulated in individual myofiber types, selected from a broader set (Supplemental Figure 2C). Exclusivity was determined by the Kruskal-Wallis test (adjusted P value < 0.05). Exclusively expressed genes were not identified in mutant MF1 fibers. (C) Venn diagram depicting the uniqueness and overlap of upregulated genes across different myofiber types, with numbers and percentages shown for both shared and unique gene sets. (D) Genes upregulated across all 4 fiber types (global response) were analyzed by gene ontology (GO) enrichment and visualized as a network. Each node represents a GO term, grouped by functional proximity within the enrichment hierarchy. Node size indicates the number of genes associated with the term, and node color reflects enrichment significance determined by 1-sided Fisher’s exact test (adjusted P value). (E) Genes selectively upregulated in specific fiber types were analyzed using compareGO. GO terms were grouped by functional proximity. Node size reflects the number of contributing genes, and node colors are shown as pie charts indicating the relative enrichment strength determined by 1-sided Fisher’s exact test (adjusted P value) contributed by each fiber type. (F) Genes globally upregulated across all fiber types and genes selectively upregulated in specific fiber types were mapped to enriched GO groups. The origin of each gene set is indicated by the stratum, and connecting threads represent gene-to-pathway relationships, colored by GO term identity.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts